To Study radioactive isotopes on treatment of chemotherapy

To Study radioactive isotopes on treatment of chemotherapy

Registration ID: IJNRD_188970

Published ID: IJNRD2303373

DOI: Click Here to Get

Shyam Gore , Pratiksha Sonawane , Samiksha Bachkar , Rushikesh Gore

Asbestos, Herbicides, Spondylitis, Epidemionlogy, Carcinoma, Maligancies,

Radiation therapy is an effective cancer treatment option in conjunction with chemotherapy and surgery. Emerging individualized internal and systemic radiation treatment promises significant improvement in efficacy and reduction of normal tissue damage; however, it requires cancer cell targeting platforms for efficient delivery of radiation sources. Abstract Purpose of Review Cardiac masses frequently present significant diagnostic and therapeutic clinical challenges and encompass Broad set of lesions that can be either neoplastic or non-neoplastic. We sought to provide an overview of cardiac tumors using Cardiac chamber prevalence approach and providing epidemiology, imaging, histopathology, diagnostic workup, treatment, and Prognoses of cardiac tumors . Radiotherapy utilization rates for cancer vary widely internationally. It has previously been suggested that approximately 50% of all cancer patients should receive radiation. The proportion of patients with cancer in whom external beam radiotherapy is indicated according to the best available evidence was calculated to be 52%. Monte Carlo analysis indicated that the 95% confidence limits were from 51.7% to 53.1%. The tightness of the confidence interval suggests that the overall estimate is robust. Comparison with actual radiotherapy utilization data suggests a shortfall in actual radiotherapy delivery. Radiopharmaceutical basically deals with the application of radioactive nuclides as a therapeutic agent in different Diseases treatment and somewhere also as sterilizing agent. The therapeutic action depends on the radiation Potential of nuclides which is utilized to terminate the cancerous cell by either implanting nuclides close to the Tumour or by selective delivery of nuclides to the malignant cells using immunobiology. Radionuclides are Outlined to be more lethal towards malignant cells in comparison to normal cells, and this stimulated the Researchers to use radionuclides in cancer treatment. ―TELETHERAPY‖ one of the method for treating deep Settled tumors is through the application of a direct powerful narrow beam of gamma rays [ϒ], emitted by an Artificial isotope, into the tumor. Cobalt-60 is most commonly used isotope for teletherapy.

Published Paper   E-Certificate

"To Study radioactive isotopes on treatment of chemotherapy", IJNRD - INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (www.IJNRD.org), ISSN:2456-4184, Vol.8, Issue 3, page no.d542-d553, March-2023, Available :https://ijnrd.org/papers/IJNRD2303373.pdf

Volume 8 Issue 3, March-2023

Pages : d542-d553

Paper Reg. ID: IJNRD_188970

Published Paper Id: IJNRD2303373

Downloads: 000121206

Research Area: Engineering

Country: -, -, -

Published Paper PDF: https://ijnrd.org/papers/IJNRD2303373.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2303373

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition

Call For Paper - Volume 10 | Issue 8 | August 2025

IJNRD is Scholarly open access journals, Peer-reviewed, and Refereed Journals, High Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool), Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) with Open-Access Publications.

INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to explore advances in research pertaining to applied, theoretical and experimental Technological studies. The goal is to promote scientific information interchange between researchers, developers, engineers, students, and practitioners working in and around the world. IJNRD will provide an opportunity for practitioners and educators of engineering field to exchange research evidence, models of best practice and innovative ideas.

Indexing In Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar | AI-Powered Research Tool, Microsoft Academic, Academia.edu, arXiv.org, Research Gate, CiteSeerX, ResearcherID Thomson Reuters, Mendeley : reference manager, DocStoc, ISSUU, Scribd, and many more

How to submit the paper?

Important Dates for Current issue

Paper Submission Open For: August 2025

Current Issue: Volume 10 | Issue 8

Last Date for Paper Submission: Till 31-Aug-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: International Peer-reviewed, Refereed, and Open Access Journal.

Subject Category: Research Area